{"id":156792,"date":"2023-03-06T17:23:00","date_gmt":"2023-03-06T17:23:00","guid":{"rendered":"https:\/\/tecscience.tec.mx\/en\/?p=156792"},"modified":"2024-12-10T17:40:20","modified_gmt":"2024-12-10T23:40:20","slug":"the-future-of-parkinsons-treatment","status":"publish","type":"post","link":"https:\/\/tecscience.tec.mx\/en\/health\/the-future-of-parkinsons-treatment\/","title":{"rendered":"Parkinson’s treatments future"},"content":{"rendered":"\n

Fortino Salazar<\/a>, a neurologist, surgeon, and researcher at the Tecnol\u00f3gico de Monterrey, is part of a group of experts in neurosciences at the Center for Parkinson’s, Movement Disorders and Neurorestoration at the Zambrano Hellion Hospital<\/strong> of the TecSalud<\/a> system.<\/p>\n\n\n\n

Since 2015, the group has focused on doing cutting-edge research and providing comprehensive and multidisciplinary treatment to people who suffer from it.<\/p>\n\n\n\n

H\u00e9ctor Ram\u00f3n Mart\u00ednez<\/strong><\/a>, director of TecSalud’s Institute of Neurology and Neurosurgery, defines the disease as the loss of the substantia nigra in which important symptoms, such as coordination problems, tremor, stiffness, and slow movement are present.<\/p>\n\n\n\n

Parkinson’s is a degenerative neurological disease that affects the brain and those parts of the body controlled by it, resulting in problems with movement. It is caused by the low production of dopamine \u2212an important neurotransmitter\u2212 and affects more than 8 million people worldwide<\/a>.<\/p>\n\n\n\n

\n